Eurepa-1 Tablet is used to manage type 2 diabetes mellitus. It contains Repaglinide, a meglitinide class medicine that stimulates the pancreas to release insulin, helping to control post-meal blood sugar levels effectively.
Besides its main use, this tablet also plays a significant role in preventing serious complications associated with diabetes. By controlling high blood sugar levels, it mitigates the risk of severe health issues such as kidney damage, nerve problems, blindness, limb amputations, and sexual dysfunction. Also, well-managed diabetes can decrease the chances of cardiovascular events like strokes and heart attacks.
For optimal results with this tablet, you should always follow your doctor's instructions regarding dosage and frequency. Before starting this medicine, inform your doctor about any ongoing medications or pre-existing conditions you have. If you experience any side effects while on this medicine, notify your doctor immediately. It's essential to continue taking the medicine for the prescribed duration for the best outcome.




































































